Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 32 | 58 | 41 | 178 | 116 |
Gross Profit | 32 | 58 | 41 | 178 | 116 |
Operating Expenses | 7,959 | 5,990 | 5,871 | 5,559 | 5,566 |
Operating Income | -7,927 | -5,932 | -5,830 | -5,381 | -5,450 |
Other Income | 282 | 284 | 185 | 139 | 154 |
Pre-tax Income | -7,645 | -5,648 | -5,645 | -5,242 | -5,296 |
Net Income Continuous | -7,645 | -5,648 | -5,645 | -5,242 | -5,296 |
Net Income | $-7,645 | $-5,648 | $-5,645 | $-5,242 | $-5,296 |
EPS Basic Total Ops | -0.29 | -0.22 | -0.24 | -0.24 | -0.24 |
EPS Basic Continuous Ops | -0.29 | -0.22 | -0.24 | -0.24 | -0.24 |
EPS Diluted Total Ops | -0.29 | -0.22 | -0.24 | -0.24 | -0.24 |
EPS Diluted Continuous Ops | -0.29 | -0.22 | -0.24 | -0.24 | -0.24 |
EBITDA(a) | $-7,711 | $-5,715 | $-5,606 | $-5,149 | $-5,211 |